Delivery Order SPE2DB25D3201-SPE2DB25FNVBQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,982.05 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in 4GM quantity. This non-competitive, firm fixed-price delivery order was awarded on May 15, 2025, with an ultimate completion date of May 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 mcg inhalation solution (4 gm) on July 22, 2025, with a ceiling value of $2,903.48. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The order is set for completion by July 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,614 for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The award was made on October 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.44 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication in 4-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- This is a $1,147.45 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, with a performance period through May 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a $196 firm fixed price delivery order to Amerisourcebergen Drug Corporation for SPIRIVA RESPIMAT 1.25 MCG INH 4GM. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania under a one-day period of performance starting on August 29, 2023. The contract was awarded utilizing Amerisourcebergen's position on an existing DLA pharmaceuticals contract vehicle. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,536.07 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription respiratory medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,649 to Amerisourcebergen Drug Corporation for SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 7-8, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, though further...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $523 to Amerisourcebergen Drug Corporation to supply SPIRIVA RESPIMAT 1.25 MCG INH 4GM. The contract has a period of performance from August 22, 2023 through August 23, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVBQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,502.36 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication used in the treatment of chronic obstructive pulmonary disease. Awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, this firm fixed-price delivery order represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This prime vendor agreement enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for multiple therapeutic domains, vaccines, and specialized medical commodities. The company's contract portfolio demonstrates its role as a critical vendor for the Defense Health Agency and other federal healthcare customers, with the ability to fulfill requirements ranging from small individual orders to substantial bulk pharmaceutical deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/23/25 |